This review summarizes clinical, epidemiological and genetic factors to propose a two-dimensional classification of melanocytic neoplasms, distinguishing disease subclasses on one axis and their evolutionary phases on the other
SSRIs (sertraline, citalopram, fluoxetine) Theres no known direct interaction between Wegovy and SSRIs
Where the Science Is Headed Now The next phase of the GLP-1 story is less about format and more about stability in the body over time, a shift that became tangible in December 2025 when the FDA approved Novo Nordisks oral semaglutide (Wegovy), the first daily GLP-1 pill cleared for obesity treatment
Retatrutide is not eligible for compounding
The goal is not to reach the maximum dose
During her time at Hopkins, she was a recipient of the prestigious William Walker Award for Psychiatric Research and published a number of peer-reviewed articles within dermatology